Case Western Reserve’s John Tilton, MD, secures 4th Falk Catalyst Award

(Case Western Reserve University) John ‘Chip’ Tilton, MD, of Case Western Reserve University School of Medicine will receive $300,000 from the Dr. Ralph and Marian Falk Medical Research Trust to develop a virus-based ‘nanoPOD’ (nanoscale PrOtein Delivery) platform to help treat rare genetic diseases. The seed funding, part of the Falk Catalyst Awards Program, will support one year of research into ways to effectively package therapies into nanoPODs, and deliver them to specific tissues in mice affected by genetic disease.